Design, Synthesis and Structure—Activity Relationships of (Indo-3-yl) Heterocyclic Derivatives as Agonists of the CB1 Receptor. Discovery of a Clinical Candidate.Paul Ratcliffe andChemInform(2011)引用 6|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要